Safety of Turoctocog alfa for Prophylaxis and Treatment of Bleeding Episodes in Patients with Severe Haemophilia A: Results from the GuardianTM2 Trial

S. Lejniece, M. Martin-Salces, I. Matytsina, L. Rageliene, A. Rosholm, E. Santagostino

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Article numberP126
Pages (from-to)98
Issue numberSuppl.2, SI
Publication statusPublished - Feb 2016
Event9th Congress of the European Association for Haemophilia and Allied Disorders - Malmö, Sweden
Duration: 3 Feb 20165 Feb 2016
Conference number: 9


  • hematology

Field of Science*

  • 3.2 Clinical medicine

Publication Type*

  • 3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Cite this